The Patent Finder

Navigo Proteins GmbH

Also on record
Records under this name other than the patents Navigo Proteins GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.

Showing 1 to 5 of 5 · Back to Navigo Proteins GmbH

PatentTitleStatus Expires Confidence
US 7,838,629Ubiquitin or Gamma-Crystalline Conjugates for Use in Therapy, Diagnosis and Chromatography
Term ended
Term ended Oct 28, 2026 · High confidence
Term endedTerm ended Oct 28, 2026High confidence
US 8,790,895Generation of artificial binding proteins on the basis of ubiquitin proteins
Lapsed on the fee record
Ended Jul 29, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 29, 2026Medium confidence
US 8,592,179Artificial binding proteins based on a modified alpha helical region of ubiquitin
Lapsed on the fee record
Ended Nov 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 26, 2025From the USPTO record
US 8,791,238Artificial Binding Proteins Based on Ubiquitin
Term ended
Ended no later than Jun 30, 2025 · Medium confidence
Term endedEnded no later than Jun 30, 2025Medium confidence
US 8,629,088Mixture of at least two fusion proteins, the production thereof and the use of the same
Lapsed on the fee record
Ended Jan 14, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jan 14, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited